Results 1 to 10 of about 478,311 (305)
Respiratory Research, 2022 Background The COMPERA 2.0 4-stratum (4-S) risk score has been demonstrated superior over the 3-stratum (3-S) one in patients with pulmonary arterial hypertension and medically managed patients with chronic thromboembolic pulmonary hypertension (CTEPH ...
Yi Zhang +13 more
doaj +1 more source
Pulmonary artery dilatation in different causes of pulmonary hypertension
Pulmonary Circulation, 2023 Pulmonary artery (PA) dilatation is commonly observed in patients with pulmonary hypertension (PH). However, the clinical aspects of PA dilatation in various etiology of PH remain unknown.
Qunying Xi +9 more
doaj +1 more source
Hypertensive Pulmonary Vascular Disease [PDF]
Circulation, 1956 Patients with pulmonary artery blood pressures that are chronically elevated to levels of the order of the systemic blood pressures, form a distinct clinicopathologic entity. This condition may complicate a ventricular septal defect, Eisenmenger's complex, patent ductus arteriosus, atrial septal defect, and mitral stenosis, and it may occur as ...
D, HEATH, W, WHITAKER
openaire +2 more sources
BMC Health Services Research, 2020 Background Extensive measures to reduce person-to-person transmission of COVID-19 are required to control the current outbreak. Special attention is directed at healthcare professionals as reducing the risk of infection in healthcare is essential.
Malene Missel +4 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Background: The hemodynamic results of balloon pulmonary angioplasty vary among patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Previous studies revealed that microvasculopathy accounted for residual pulmonary hypertension
Xin Li +15 more
doaj +1 more source
Diagnostic and prognostic value of ventilatory power in pulmonary hypertension
Respiratory Research, 2022 Background Ventilatory power is a novel index which could reflect both ventilation efficiency and peripheral blood flow. However, its clinical value in pulmonary hypertension (PH) is rarely discussed.
Xin Li +11 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Background: The current medical treatments for connective tissue disease–associated pulmonary arterial hypertension (CTD-PAH) do not show favorable efficiency for all patients, and identification of novel drugs is desired.Methods: Text mining was ...
Jiang-Shan Tan +4 more
doaj +1 more source
Carbohydrate Antigen 125 Is a Biomarker of the Severity and Prognosis of Pulmonary Hypertension
Frontiers in Cardiovascular Medicine, 2021 Background: Emerging evidence has showed that serum carbohydrate antigen 125 (CA 125) levels are associated with the severity and prognosis of heart failure. However, its role in pulmonary hypertension remains unclear. This study aimed to investigate the
Yi Zhang +14 more
doaj +1 more source
Creatine kinase is associated with bleeding after myocardial infarction
Open Heart, 2020 Background The ADP-scavenging enzyme creatine kinase (CK) is reported to reduce ADP-dependent platelet activation. Therefore, we studied whether highly elevated CK after ST-elevation myocardial infarction (STEMI) is associated with bleeding.Methods Data ...
Jesper Hastrup Svendsen +4 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 BackgroundDysfunction of autonomic nervous system plays an important role in the development of pulmonary hypertension. The present study aimed to investigate the interaction between balloon pulmonary angioplasty (BPA) and cardiac autonomic function by ...
Yi Zhang +14 more
doaj +1 more source